The cytogenetic abnormalities inv (16)(p13.1q22)/t(16;16)(p13.1;q22)[hereafter referred to as inv (16)] and t(8;21)(q22;q22), commonly referred to as core binding factor (CBF) acute myeloid leukemia (AML) [1]. Here, CEBPZ is linked to acute myeloid leukemia.